Ticker Details
Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.
IPO Date:	January 1, 1987
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.71B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 2.45%
Avg Daily Range (30 D):	$0.76 | 2.41%
Avg Daily Range (90 D):	$0.69 | 2.17%

Institutional Daily Volume
Avg Daily Volume:	.29M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	.78M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	57

Institutional Trades
Total Institutional Trades:	1,496
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$2.56M
Avg Institutional Trade (90 D):	$2.2M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.63M
Avg Closing Trade (30 D):	$4.51M
Avg Closing Trade (90 D):	$3.64M
Avg Closing Volume:	84.87K

News

Feb 17, 2026 @ 12:00 PM Axogen, Inc. to Participate in Multiple Upcoming I... Source: Na

Feb 10, 2026 @ 12:00 PM Axogen, Inc. to Report Fourth Quarter and Full Yea... Source: Na

Jan 22, 2026 @ 4:18 AM Axogen Announces Pricing of Upsized $124 Million P... Source: Na

Jan 12, 2026 @ 12:00 PM Axogen, Inc. Reports Preliminary Unaudited Revenue... Source: Na

Dec 4, 2025 @ 1:01 AM Axogen Announces FDA Approval of Biologics License... Source: Axogen, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.34	$-.28	$-.34
Diluted EPS	$-.34	$-.28	$-.34
Revenue	$225.21M	$59.9M	$225.21M
Gross Profit	$167.35M	$44.41M	$167.35M
Net Income / Loss	$-15.7M	$-13.16M	$-15.7M
Operating Income / Loss	$-7.85M	$-9.77M	$-7.85M
Cost of Revenue	$57.86M	$15.5M	$57.86M
Net Cash Flow	$5.99M	$11.65M	$5.99M
PE Ratio